Genomic Understanding Reveals the Important Role of FGFR2 as Paeoniflorin Target for Circumventing Breast Cancer Resistance to Tamoxifen.

Moh Arikus WibowoEri Prasetyo NugrohoAdam Hermawan

Published in: Asian Pacific journal of cancer prevention : APJCP (2021)

PF has potential to be used as a co-treatment for circumventing breast cancer resistance to tamoxifen by targeting FGFR2 signaling, but further validation is needed.

Keyphrases

estrogen receptor
breast cancer cells
positive breast cancer
copy number
risk assessment
young adults
dna methylation
replacement therapy